Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis

HER2/ERBB2 amplification/overexpression determines the eligibility of breast cancer patients to HER2-targeted therapy. This study evaluates the agreement between ERBB2 copy number assessment by fluorescence in situ hybridization, a standard method recommended by the American Society of Clinical Onco...

Descripción completa

Detalles Bibliográficos
Autores principales: Christgen, Matthias, van Luttikhuizen, Jana L., Raap, Mieke, Braubach, Peter, Schmidt, Lars, Jonigk, Danny, Feuerhake, Friedrich, Lehmann, Ulrich, Schlegelberger, Brigitte, Kreipe, Hans H., Steinemann, Doris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347728/
https://www.ncbi.nlm.nih.gov/pubmed/27716627
http://dx.doi.org/10.18632/oncotarget.12421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347728/
https://www.ncbi.nlm.nih.gov/pubmed/27716627
http://dx.doi.org/10.18632/oncotarget.12421

Ejemplares similares